Advanced lung cancer inflammation index is associated with long-term cardiovascular death in hypertensive patients: national health and nutrition examination study, 1999–2018

Background: Hypertension is one of the main causes of cardiovascular death. Inflammation was considered influential factors of cardiovascular (CVD) death in patients with hypertension. Advanced lung cancer inflammation index (ALI) is an index to assess inflammation, few studies have investigated the...

Full description

Bibliographic Details
Main Authors: Jiabin Tu, Bo Wu, Jiaming Xiu, Jiayi Deng, Shuqiong Lin, Jin Lu, Yanfang Yan, Pei Yu, Jinlong Zhu, Kaihong Chen, Shan Ding, Liling Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2023.1074672/full
_version_ 1797834717084516352
author Jiabin Tu
Bo Wu
Jiaming Xiu
Jiayi Deng
Shuqiong Lin
Jin Lu
Yanfang Yan
Pei Yu
Jinlong Zhu
Kaihong Chen
Shan Ding
Liling Chen
author_facet Jiabin Tu
Bo Wu
Jiaming Xiu
Jiayi Deng
Shuqiong Lin
Jin Lu
Yanfang Yan
Pei Yu
Jinlong Zhu
Kaihong Chen
Shan Ding
Liling Chen
author_sort Jiabin Tu
collection DOAJ
description Background: Hypertension is one of the main causes of cardiovascular death. Inflammation was considered influential factors of cardiovascular (CVD) death in patients with hypertension. Advanced lung cancer inflammation index (ALI) is an index to assess inflammation, few studies have investigated the relationship between advanced lung cancer inflammation index and cardiovascular death in hypertensive patients.Objective: The aim of this study was to investigate the association between advanced lung cancer inflammation index and long-term cardiovascular death in hypertensive patients.Method: Data from the National Health and Nutrition Examination Survey (NHANES) 1999–2018 with mortality follow-up through 31 December 2019 were analyzed. Advanced lung cancer inflammation index was calculated as BMI (kg/㎡) × serum albumin level (g/dL)/neutrophil to lymphocyte ratio (NLR). A total of 20,517 participants were evaluated. Patients were divided into three groups based on tertiles of advanced lung cancer inflammation index as follows: T1 (n = 6,839), T2 (n = 6,839), and T3 (n = 6,839) groups. The relationship between advanced lung cancer inflammation index and long-term cardiovascular death was assessed by survival curves and Cox regression analysis based on the NHANES recommended weights.Results: The median advanced lung cancer inflammation index value in this study was 61.9 [44.4, 84.6]. After full adjustment, the T2 group (hazard ratio [HR]: 0.59, 95% confidence interval [CI]: 0.50–0.69; p < 0.001) and T3 group (HR: 0.48, 95% CI: 0.39–0.58; p < 0.001) were found to have a significantly lower risk of cardiovascular death compared to the T1 group.Conclusion: High levels of advanced lung cancer inflammation index were associated with reduced risk of cardiovascular death in hypertensive patients.
first_indexed 2024-04-09T14:42:00Z
format Article
id doaj.art-1ecfbc8f3df4498b9a69d62caa8e790d
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-04-09T14:42:00Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-1ecfbc8f3df4498b9a69d62caa8e790d2023-05-03T05:18:33ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2023-05-011410.3389/fphys.2023.10746721074672Advanced lung cancer inflammation index is associated with long-term cardiovascular death in hypertensive patients: national health and nutrition examination study, 1999–2018Jiabin Tu0Bo Wu1Jiaming Xiu2Jiayi Deng3Shuqiong Lin4Jin Lu5Yanfang Yan6Pei Yu7Jinlong Zhu8Kaihong Chen9Shan Ding10Liling Chen11Longyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaLongyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaLongyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaLongyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaZhangzhou Affiliated Hospital to Fujian Medical University, Zhangzhou, ChinaLongyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaLongyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaLongyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaLongyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaLongyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaZhongshan Hospital (Xiamen), Fudan University, Xiamen, ChinaLongyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaBackground: Hypertension is one of the main causes of cardiovascular death. Inflammation was considered influential factors of cardiovascular (CVD) death in patients with hypertension. Advanced lung cancer inflammation index (ALI) is an index to assess inflammation, few studies have investigated the relationship between advanced lung cancer inflammation index and cardiovascular death in hypertensive patients.Objective: The aim of this study was to investigate the association between advanced lung cancer inflammation index and long-term cardiovascular death in hypertensive patients.Method: Data from the National Health and Nutrition Examination Survey (NHANES) 1999–2018 with mortality follow-up through 31 December 2019 were analyzed. Advanced lung cancer inflammation index was calculated as BMI (kg/㎡) × serum albumin level (g/dL)/neutrophil to lymphocyte ratio (NLR). A total of 20,517 participants were evaluated. Patients were divided into three groups based on tertiles of advanced lung cancer inflammation index as follows: T1 (n = 6,839), T2 (n = 6,839), and T3 (n = 6,839) groups. The relationship between advanced lung cancer inflammation index and long-term cardiovascular death was assessed by survival curves and Cox regression analysis based on the NHANES recommended weights.Results: The median advanced lung cancer inflammation index value in this study was 61.9 [44.4, 84.6]. After full adjustment, the T2 group (hazard ratio [HR]: 0.59, 95% confidence interval [CI]: 0.50–0.69; p < 0.001) and T3 group (HR: 0.48, 95% CI: 0.39–0.58; p < 0.001) were found to have a significantly lower risk of cardiovascular death compared to the T1 group.Conclusion: High levels of advanced lung cancer inflammation index were associated with reduced risk of cardiovascular death in hypertensive patients.https://www.frontiersin.org/articles/10.3389/fphys.2023.1074672/fullhypertensioninflammationcardiovascular deathadvanced lung cancer inflammation indexNHANES
spellingShingle Jiabin Tu
Bo Wu
Jiaming Xiu
Jiayi Deng
Shuqiong Lin
Jin Lu
Yanfang Yan
Pei Yu
Jinlong Zhu
Kaihong Chen
Shan Ding
Liling Chen
Advanced lung cancer inflammation index is associated with long-term cardiovascular death in hypertensive patients: national health and nutrition examination study, 1999–2018
Frontiers in Physiology
hypertension
inflammation
cardiovascular death
advanced lung cancer inflammation index
NHANES
title Advanced lung cancer inflammation index is associated with long-term cardiovascular death in hypertensive patients: national health and nutrition examination study, 1999–2018
title_full Advanced lung cancer inflammation index is associated with long-term cardiovascular death in hypertensive patients: national health and nutrition examination study, 1999–2018
title_fullStr Advanced lung cancer inflammation index is associated with long-term cardiovascular death in hypertensive patients: national health and nutrition examination study, 1999–2018
title_full_unstemmed Advanced lung cancer inflammation index is associated with long-term cardiovascular death in hypertensive patients: national health and nutrition examination study, 1999–2018
title_short Advanced lung cancer inflammation index is associated with long-term cardiovascular death in hypertensive patients: national health and nutrition examination study, 1999–2018
title_sort advanced lung cancer inflammation index is associated with long term cardiovascular death in hypertensive patients national health and nutrition examination study 1999 2018
topic hypertension
inflammation
cardiovascular death
advanced lung cancer inflammation index
NHANES
url https://www.frontiersin.org/articles/10.3389/fphys.2023.1074672/full
work_keys_str_mv AT jiabintu advancedlungcancerinflammationindexisassociatedwithlongtermcardiovasculardeathinhypertensivepatientsnationalhealthandnutritionexaminationstudy19992018
AT bowu advancedlungcancerinflammationindexisassociatedwithlongtermcardiovasculardeathinhypertensivepatientsnationalhealthandnutritionexaminationstudy19992018
AT jiamingxiu advancedlungcancerinflammationindexisassociatedwithlongtermcardiovasculardeathinhypertensivepatientsnationalhealthandnutritionexaminationstudy19992018
AT jiayideng advancedlungcancerinflammationindexisassociatedwithlongtermcardiovasculardeathinhypertensivepatientsnationalhealthandnutritionexaminationstudy19992018
AT shuqionglin advancedlungcancerinflammationindexisassociatedwithlongtermcardiovasculardeathinhypertensivepatientsnationalhealthandnutritionexaminationstudy19992018
AT jinlu advancedlungcancerinflammationindexisassociatedwithlongtermcardiovasculardeathinhypertensivepatientsnationalhealthandnutritionexaminationstudy19992018
AT yanfangyan advancedlungcancerinflammationindexisassociatedwithlongtermcardiovasculardeathinhypertensivepatientsnationalhealthandnutritionexaminationstudy19992018
AT peiyu advancedlungcancerinflammationindexisassociatedwithlongtermcardiovasculardeathinhypertensivepatientsnationalhealthandnutritionexaminationstudy19992018
AT jinlongzhu advancedlungcancerinflammationindexisassociatedwithlongtermcardiovasculardeathinhypertensivepatientsnationalhealthandnutritionexaminationstudy19992018
AT kaihongchen advancedlungcancerinflammationindexisassociatedwithlongtermcardiovasculardeathinhypertensivepatientsnationalhealthandnutritionexaminationstudy19992018
AT shanding advancedlungcancerinflammationindexisassociatedwithlongtermcardiovasculardeathinhypertensivepatientsnationalhealthandnutritionexaminationstudy19992018
AT lilingchen advancedlungcancerinflammationindexisassociatedwithlongtermcardiovasculardeathinhypertensivepatientsnationalhealthandnutritionexaminationstudy19992018